A team of scientists from the University of North Carolina School of Medicine, North Carolina State University’s College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell lymphoma by examining molecular similarities and differences between the two species.
Better treatments for people suffering from compromised intestinal immunity may emerge from a small-animal model of human intestinal immune development.
Kathy DeClue of Randolph County was featured in Family House Diaries in August 2012. She celebrated the success of a second stem cell transplant for leukemia by renewing her wedding vows with her husband of 41 years before 80 friends and family.
Clinical geneticist James Evans, MD, PhD helped to open the exhibition, Genome: Unlocking Life's Code. The high-tech, high-intensity display celebrates the 10th anniversary of production of the first complete human genome sequence also known as the genetic blueprint of the human body.
A research team, including UNC scientists, reports that including the positive effect of aspirin on cancer mortality influences the threshold for prescribing aspirin for primary prevention in men.
The study will focus on assessing the impact of a clinic-based intervention that includes having patients view a multimedia decision aid (in English or Spanish) before seeing their physician, as well as support from a bilingual patient “navigator” on completion of recommended colon cancer screening tests.
New research from the UNC School of Medicine has shown how a protein called UHRF1 “reads” the histone code in a specific way to perform an important cellular function.
Are there enough clinical trials data to guide every radiation oncology decision in a cancer patient's care? Not necessarily, according to a UNC School of Medicine study.
A University of North Carolina School of Medicine team offers first evidence of the role of a protein called GSK-3 alpha in promoting oncogenic KRAS function.
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from UNC suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
An Ashe County man witnesses random acts of kindness daily – both as a deliberate and often anonymous giver and as an ever-grateful receiver – while in Chapel Hill for the treatment of non-Hodgkin lymphoma.
The antibody, created at the University of North Carolina, is the first therapeutic discovered that targets a protein known as SFRP2.
Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.
A Dare County real estate agent refuses to let a breast cancer diagnosis and its treatment detract from her trademark sense of humor and constant outreach to others.
In the first application of this approach, the UNC researchers showed how a protein called Src kinase influences the way cells extend and move, a previously unknown role that is consistent with the protein’s ties to tumor progression and metastasis.
A team led by Dr. Stanley Lemon discovered that hepatitis A virus does not have an envelope when found in the environment, but acquires one from the cells that it grows in within the liver. It circulates in the blood completely cloaked in these membranes.
Tammy Cotton, a housekeeper who works at UNC Lineberger Comprehensive Cancer Center and the Thurston Bowles building, and James R. “Bud” Harper, retired associate dean of medical alumni affairs, received awards. The Massey Award is one of the most coveted distinctions the University gives faculty and staff.
The study is the first published population-based examination of racial disparities in prostate cancer treatment delay.
Researchers in the lab of Carol Otey, PhD, found that the protein palladin enhances the ability of cancer-associated fibroblasts (CAFs) to assemble organelles known as invadopodia to break down the barriers between cells and create pathways for tumors to spread throughout the body.
Dr. Oliver Smithies, Weatherspoon Eminent Distinguished Professor in the Department of Pathology and Laboratory Medicine, is a 2007 Nobel Laureate whose work revolutionized research into the genetic basis of cancer.